Human Albumin Baxalta 50 g/l inf. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin baxalta 50 g/l inf. sol. i.v. vial

baxalta innovations gmbh - albumin human 50 g/l - solution for infusion - 50 g/l - albumin human 50 mg/ml - albumin

XULTOPHY Israel - inglês - Ministry of Health

xultophy

novo nordisk ltd., israel - insulin degludec; liraglutide - solution for injection - insulin degludec 100 u/ml; liraglutide 3.6 mg/ml - insulin degludec and liraglutide - xultophy® is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to other oral medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control, and the population studied, see sections 4.4, 4.5 and 5.1

Human Albumin CSL Behring 200 g/l inf. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin csl behring 200 g/l inf. sol. i.v. vial

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

Human Albumin CSL Behring 200 g/l inf. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin csl behring 200 g/l inf. sol. i.v. vial

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin